共 50 条
- [31] 18F-FDG PET/CT CONTRIBUTION IN THE ASSESSMENT OF RESPONSE IN PATIENTS WITH MULTIPLE MYELOMA: PRELIMINARY DATA [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 438 - 438
- [32] Dual time point 18F-FDG PET/CT in patients on suspicion of malignant lymphoma [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
- [33] Prognostic impact of 18F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment [J]. International Journal of Hematology, 2021, 113 : 668 - 674
- [34] 18F-FDG PET/CT Findings and Baseline Clinical Parameters in Multiple Myeloma [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E148 - E149
- [35] Response evaluation in multiple myeloma: A prospective study with 18F-FDG PET/CT [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
- [37] Prognostic value of metabolic activity measured by 18F-FDG PET/CT in Patients with Multiple Myeloma [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
- [38] 18F-FDG PET/CT in multiple myeloma: critical insights and future directions [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1048 - 1050
- [39] 18F-FDG PET/CT can be used to predict progression in smoldering multiple myeloma patients [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S134 - S134